Kamran Khalid is a results-oriented pharmaceutical commercial executive with over 25 years of experience in the oncology field. Currently, they serve as the Global Commercial Head for TROP2 ADC Lung Cancer at AstraZeneca, having previously held positions such as Global Commercial Director for Pan-Tumor Dato-DXd and Director of Brand Marketing for EGFR Lung Cancer. Kamran's diverse background includes leadership roles at Eli Lilly, Supernus Pharmaceuticals, OSI Pharmaceuticals, and Astellas Pharma, where they contributed to various aspects of oncology sales and marketing. They earned a BS degree from the University of Maryland in 2000.
This person is not in any teams
This person is not in any offices